We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MKGAF market cap is 21.22B. The company's latest EPS is EUR and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 16.15B | 17.53B | 19.69B | 22.23B | 20.99B |
| Operating Income | 2.2B | 2.96B | 4.12B | 4.52B | 3.48B |
| Net Income | 1.32B | 1.99B | 3.06B | 3.33B | 2.82B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 43.81B | 41.8B | 45.36B | 48.54B | 48.5B |
| Total Liabilities | 25.9B | 24.78B | 23.95B | 22.53B | 21.74B |
| Total Equity | 17.91B | 17.02B | 21.42B | 26.01B | 26.75B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 2.86B | 3.48B | 4.62B | 4.26B | 3.78B |
| Investing | -6.15B | -1.34B | -1.58B | -2.74B | -1.89B |
| Financing | 1.9B | -1.52B | -2.5B | -1.56B | -1.73B |
| Market Cap | 21.22B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | 1.23% |
| Shares Outstanding | 129.24M |
| Average Volume (1 week) | 302 |
| Average Volume (1 Month) | 153 |
| 52 Week Change | 3.66% |
| 52 Week High | 200.56 |
| 52 Week Low | 144.725 |
| Spread (Intraday) | 8.8 (5.1%) |
| Company Name | Merck KGAA (PK) |
| Address |
frankfurter strasse 250 darmstadt 64293 |
| Website | https://www.merck.de |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
